Dow Jones

39 069,59

0,01%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Atherogenics (MM) (AGIX)
Atherogenics (MM) (AGIX) Actualités

AGIX

Atherogenics (AGIX)

Atherogenics (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:AGIX

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
10/10/2008	23h23	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AGIX	Atherogenics (MM)
10/10/2008	23h15	Marketwired	AtheroGenics Receives Delisting Notice From NASDAQ Global Market Due to Chapter 11 Filing	NASDAQ:AGIX	Atherogenics (MM)
10/10/2008	21h35	Edgar (US Regulatory)	Withdrawal of Registration Statement (RW)	NASDAQ:AGIX	Atherogenics (MM)
07/10/2008	14h20	Edgar (US Regulatory)	Atherogenics Inc - Current report filing (8-K)	NASDAQ:AGIX	Atherogenics (MM)
07/10/2008	12h51	Marketwired	AtheroGenics Files for Chapter 11 Bankruptcy	NASDAQ:AGIX	Atherogenics (MM)
11/09/2008	01h13	Marketwired	AtheroGenics Restructures Board of Directors	NASDAQ:AGIX	Atherogenics (MM)
02/09/2008	17h44	Marketwired	BellwetherReport.com Analyst Opinions on SCRX, AGIX, BUCY and ISIL	NASDAQ:AGIX	Atherogenics (MM)
02/09/2008	14h39	Marketwired	AtheroGenics Seeks to Realign Capital Structure	NASDAQ:AGIX	Atherogenics (MM)
25/08/2008	21h00	Edgar (US Regulatory)	Atherogenics Inc - Confidential Treatment Order (CT ORDER)	NASDAQ:AGIX	Atherogenics (MM)
20/08/2008	12h24	Edgar (US Regulatory)	Atherogenics Inc - Application for qualification of trust indentures (T-3)	NASDAQ:AGIX	Atherogenics (MM)
05/08/2008	13h00	Marketwired	AtheroGenics Reports Second Quarter 2008 Financial Results	NASDAQ:AGIX	Atherogenics (MM)
01/08/2008	16h20	PR Newswire (US)	BeaconEquity.com Issues Technical Trade Alerts on Market Movers: AGIX, APKT, BIOS, NOVA, CNXT, CHRD	NASDAQ:AGIX	Atherogenics (MM)
31/07/2008	17h27	Marketwired	BellwetherReport.com Analyst Report on HOLX, AKAM, SBUX and AGIX	NASDAQ:AGIX	Atherogenics (MM)
31/07/2008	13h00	Marketwired	AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes	NASDAQ:AGIX	Atherogenics (MM)
25/07/2008	13h15	Marketwired	AtheroGenics to Report Second Quarter 2008 Financial Results on August 5, 2008	NASDAQ:AGIX	Atherogenics (MM)
30/06/2008	15h21	Marketwired	AtheroGenics Receives Notice of Non-Compliance With Listing Requirement for the NASDAQ Global Market	NASDAQ:AGIX	Atherogenics (MM)
19/06/2008	15h20	PR Newswire (US)	BeaconEquity.com Issues TraderNotes on Stocks: TPIM, NSM, BRLC, AGIX, AROX, TLEO, HLYS, ABAT	NASDAQ:AGIX	Atherogenics (MM)
10/06/2008	15h17	Marketwired	AtheroGenics Reports Clinical Data on Novel Anti-Inflammatory Anti-Oxidant Agent, AGI-1067, at American Diabetes Association Ann	NASDAQ:AGIX	Atherogenics (MM)
04/06/2008	13h30	Marketwired	AtheroGenics Announces Five Abstracts Accepted for the American Diabetes Association's 68th Annual Scientific Sessions	NASDAQ:AGIX	Atherogenics (MM)
23/05/2008	21h38	Edgar (US Regulatory)	Atherogenics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGIX	Atherogenics (MM)
23/05/2008	02h55	Marketwired	AtheroGenics' ARISE Trial Results Published in The Lancet	NASDAQ:AGIX	Atherogenics (MM)
09/05/2008	23h10	Edgar (US Regulatory)	Atherogenics Inc - Quarterly Report (10-Q)	NASDAQ:AGIX	Atherogenics (MM)
30/04/2008	20h51	Marketwired	/ CORRECTION - AtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008	NASDAQ:AGIX	Atherogenics (MM)
30/04/2008	16h57	Marketwired	AtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008	NASDAQ:AGIX	Atherogenics (MM)
24/04/2008	13h00	Marketwired	AtheroGenics Reports First Quarter 2008 Financial Results	NASDAQ:AGIX	Atherogenics (MM)
18/04/2008	15h33	Edgar (US Regulatory)	Atherogenics Inc - Proxy Statement (definitive) (DEF 14A)	NASDAQ:AGIX	Atherogenics (MM)
17/04/2008	15h18	Marketwired	AtheroGenics to Report First Quarter 2008 Financial Results on April 24, 2008	NASDAQ:AGIX	Atherogenics (MM)
14/04/2008	13h00	Marketwired	AtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes	NASDAQ:AGIX	Atherogenics (MM)
07/04/2008	22h38	Edgar (US Regulatory)	Atherogenics Inc - Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:AGIX	Atherogenics (MM)
11/03/2008	14h31	Marketwired	AtheroGenics to Present at Lehman Brothers Global Healthcare Conference March 18, 2008	NASDAQ:AGIX	Atherogenics (MM)